2023, Volume 8
2022, Volume 7
2021, Volume 6
2020, Volume 5
2019, Volume 4
2018, Volume 3
2017, Volume 2
2016, Volume 1
Submit a Manuscript
Publishing with us to make your research visible to the widest possible audience.
Nuclear Medicine Department, NORI Hospital (AECH), Islamabad, Pakistan
For the purpose of identifying active bone lesions, 99m-methylene diphosphonate (MDP) whole body scintigraphy is the method of choice. There are numerous mechanisms that have been reported to lead to extraosseous radiopharmaceutical uptake on bone scintigraphy that must be understood in order to ascertain the underlying cause. Since these unexpected distributions of radiotracer activity on bone scintigraphy frequently result from technical causes, artifacts, and pitfalls related to quality control, the first step when these findings appear on the bone scan is to confirm or rule out these factors. In addition, they might affect other scans that department performed that day (for instance, colloid impurities caused by aluminum breakthrough in the molybdenum-technetium generator during 99mTc-MDP preparation could affect a wide range of radionuclide studies). It is mostly used to find bone damage caused by infections and other conditions as well as to help diagnose various bone-related conditions like primary or metastatic bone cancer, the location of bone inflammation, and fractures that may not be visible on traditional X-ray images. On a whole-body bone scan, pathologies of other systems can also be found by accident. In this paper, we present a captivating image of appearance thyroid gland on bone scan.
Euthyroid, Bone Scan, Thyroid Gland, Thyroid Function Tests
Ayesha Ammar, Kahkashan Bashir, Sadaf Batool, Adnan Saeed. (2023). Appearance of Thyroid Gland on Bone Scan, Case of Euthyroid Sick Syndrome. International Journal of Diabetes and Endocrinology, 8(2), 28-30. https://doi.org/10.11648/j.ijde.20230802.11
Copyright © 2023 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
|1.||Brennan MD, Bahn RS: Thyroid hormones and illness. Endocr Pract 4: 396–403, 1998.|
|2.||Akbaş T, Sahin İE, Ozturk A. Alterations in thyroid hormones in brain-dead patients are related to non-thyroidal illness syndrome. Endokrynol Pol. 2018; 69 (5): 545-549. [PubMed].|
|3.||Gutch M, Kumar S, Gupta KK. Prognostic Value of Thyroid Profile in Critical Care Condition. Indian J Endocrinol Metab. 2018 May-Jun; 22 (3): 387-391.|
|4.||Small ridge RC. Metabolic and anatomic thyroid emergencies: a review. Crit Care Med. 1992 Feb; 20 (2): 276-91. [PubMed]|
|5.||Zhang JQ, Yang QY, Xue FS, Zhang W, Yang GZ, Liao X, Meng FM. Preoperative oral thyroid hormones to prevent euthyroid sick syndrome and attenuate myocardial ischemia-reperfusion injury after cardiac surgery with cardiopulmonary bypass in children: A randomized, double-blind, placebo-controlled trial. Medicine (Baltimore). 2018 Sep; 97 (36): e12100. [PMC free article] [PubMed]|
|6.||Nistal-Nuño B. Euthyroid sick syndrome in paediatric and adult patients requiring extracorporeal circulatory support and the role of thyroid hormone supplementation: a review. Perfusion. 2021 Jan; 36 (1): 21-33. [PubMed]|
|7.||Langsteger W, Rezaee A, Pirich C, Beheshti M. 18F-NaF-PET/CT and 99mTc MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer. Semin Nucl Med. 2016; 46: 491–501.|
|8.||Subramanian G, McAfee JG. A new complex for 99mTc for skeletal imaging. Radiology. 1971; 99: 192–196. [PubMed] [Google Scholar].|
|9.||Subramanian G, McAfee JG, Blair RJ, Kallfelz FA, Thomas FD. Technetium-99m methylene diphosphonate: a superior agent for skeletal imaging: comparison with other technetium cornplexes. J Nucl Med. 1975; 16: 744–755.|
|10.||Peller PJ, Ho VB, Kransdorf MJ. Extraosseous Tc-99m MDP uptake: a pathophy-siologic approach. Radiographics. 1993; 13: 715–734. [PubMed] [Google Scholar].|
|11.||Bares R. Skeletal scintigraphy in breast cancer management. QJ Nucl Med. 1998; 42: 43–48. [PubMed] [Google Scholar].|
|12.||Padhy AK, Gopinath PG, Amini AC. Myocardial, pulmonary, diaphragmatic, gastric, splenic, and renal uptake ofTc-99m MDP inpatients with persistent, severe hypercalcemia. Clin NucI Med. 1990; 15: 648–664.|
|13.||Lang TF, Hasegawa BH, Liew SC, et al. Description of a prototype emission-transmission computed tomography imaging system. J Nucl Med 1992; 33: 1881–1887 [Medline] [Google Scholar]|
|14.||Gnanasegaran G, Barwick T, Adamson K, Mohan H, Sharp D, Fogelman I. Multislice SPECT/CT in benign and malignant bone disease: when the ordinary turns into the extraordinary. Semin Nucl Med 2009; 39: 431–442.|
|15.||Incidental Tc-99m Methylene Diphosphonate Uptake in an Active Thyroid Nodule Derya Çayır, Mine Araz, Şafak Akın, Melia Karaköse, and Erman Çakal, published in molecular imaging and radionuclide ther, 2017.|